{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T19:52:59Z","timestamp":1696362779312},"reference-count":21,"publisher":"Informa Healthcare","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1185\/030079905x46331","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T09:33:10Z","timestamp":1124184790000},"page":"913-921","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events"],"prefix":"10.1185","volume":"21","author":[{"given":"Stefano","family":"Capri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Perlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,5,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"CIT0002","author":"World Health Organization","year":"1999","journal-title":"The world health report 1999: Making a difference. Geneva"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07495-8"},{"key":"CIT0004","author":"American Heart Association","year":"2003","journal-title":"Heart Disease and Stroke Statistics \u2013 2004 Update. Dallas"},{"key":"CIT0005","author":"ISTAT","year":"2001","journal-title":"Tavole di mortalit\u00e0 della popolazione italiana per provincia e regione di residenza. Anno 1998. Istituto Nazionale di Statistica"},{"key":"CIT0006","author":"Linstone H","year":"1975","journal-title":"The Delphi method: Techniques and applications. Reading"},{"key":"CIT0007","unstructured":"L\u2019Informatore Farmaceutico. Aggiornamento Giugno 2004 (Italian National Formulary). Milan, OEMF, 2004"},{"key":"CIT0010","first-page":"651","volume":"21","author":"Levy E","year":"2003","journal-title":"The Comparative Medical Costs of Atherothrombotic Disease in European Countries. Pharmacoeconomics"},{"key":"CIT0013","first-page":"95","volume":"3","author":"Briggs AH","year":"1994","journal-title":"Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7210.635"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.29.3.300"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300105094"},{"key":"CIT0018","first-page":"148","volume":"340","author":"Discounting health care","year":"1992","journal-title":"only a matter of timing? Lancet"},{"key":"CIT0019","first-page":"539","volume":"85","author":"Malik IS","year":"2001","journal-title":"Cost effectiveness of ramipril treatment for cardiovascular risk reduction. Heart"},{"key":"CIT0020","first-page":"508","volume":"251","author":"Bj\u00f6rholt I","year":"2002","journal-title":"al. The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study. J Intern Med"},{"key":"CIT0021","first-page":"515","volume":"19","author":"Hart WM","year":"2002","journal-title":"An Med Interna"},{"key":"CIT0022","first-page":"955","volume":"22","author":"Sch\u00e4dlich PK","year":"2004","journal-title":"Cost effectiveness of ramipril in patients at high risk for cardiovascular events. Economic evaluation of the hope (heart outcomes prevention evaluation) study for Germany from the statutory health insurance perspective. Pharmacoeconomics"},{"key":"CIT0023","first-page":"217","volume":"6","author":"Buxton MJ","year":"1997","journal-title":"Modelling in economic evaluation: An unavoidable fact of life. Health Economics"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000050600.49419.25"},{"key":"CIT0026","author":"American Heart Association","year":"2003","journal-title":"Heart disease and stroke statistics \u2013 2004 Update. Dallas"},{"key":"CIT0027","first-page":"1248","volume":"25","author":"Carroll CA","year":"2003","journal-title":"Assessment of the Effect of Ramipril Therapy on Direct Health Care Costs for First and Recurrent Strokes in High-Risk Cardiovascular Patients Using Data from the Heart Outcomes Prevention Evaluation (HOPE) Study. Clinical Therapeutics"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079905X46331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:44:22Z","timestamp":1481618662000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079905X46331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,12]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,4,25]]},"published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1185\/030079905X46331"],"URL":"https:\/\/doi.org\/10.1185\/030079905x46331","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,12]]}}}